Lindemann A - Search Results

1

Evidence for an alpha helical T cell epitope in the C-terminus of the main birch pollen allergen Bet V 1.

Kungl AJ, Susani M, Lindemann A, Machius M, Visser AJ, Scheiner O, Kraft D, Breitenbach M, Auer M. Kungl AJ, et al. Among authors: lindemann a. Biochem Biophys Res Commun. 1996 Jun 5;223(1):187-92. doi: 10.1006/bbrc.1996.0867. Biochem Biophys Res Commun. 1996. PMID: 8660368

2

Secondary structure and tertiary fold of the birch pollen allergen Bet v 1 in solution.

Faber C, Lindemann A, Sticht H, Ejchart A, Kungl A, Susani M, Frank RW, Kraft D, Breitenbach M, Rösch P. Faber C, et al. Among authors: lindemann a. J Biol Chem. 1996 Aug 9;271(32):19243-50. doi: 10.1074/jbc.271.32.19243. J Biol Chem. 1996. PMID: 8702605 Free article.

3

Direct effects of phosphorylation on the preferred backbone conformation of peptides: a nuclear magnetic resonance study.

Tholey A, Lindemann A, Kinzel V, Reed J. Tholey A, et al. Among authors: lindemann a. Biophys J. 1999 Jan;76(1 Pt 1):76-87. doi: 10.1016/S0006-3495(99)77179-1. Biophys J. 1999. PMID: 9876124 Free PMC article.

4

Overexpression and structural characterization of the phage T4 protein DsbA.

Sieber P, Lindemann A, Boehm M, Seidel G, Herzing U, van der Heusen P, Müller R, Rüger W, Jaenicke R, Rösch P. Sieber P, et al. Among authors: lindemann a. Biol Chem. 1998 Jan;379(1):51-8. doi: 10.1515/bchm.1998.379.1.51. Biol Chem. 1998. PMID: 9504717

5

Structure of the LAV6 peptide: a nucleation site for the correct receptor-induced refolding of the CD4-binding domain of HIV1 gp 120.

Lindemann A, Kinzel V, Rösch P, Reed J. Lindemann A, et al. Proteins. 1997 Oct;29(2):203-11. doi: 10.1002/(sici)1097-0134(199710)29:2<203::aid-prot8>3.0.co;2-d. Proteins. 1997. PMID: 9329085

6

Interleukin-3: structure and function.

Lindemann A, Mertelsmann R. Lindemann A, et al. Cancer Invest. 1993;11(5):609-23. doi: 10.3109/07357909309011680. Cancer Invest. 1993. PMID: 8402229 Review. No abstract available.

7

Expression of functional receptors for interleukin-6 by human polymorphonuclear leukocytes. Downregulation by granulocyte-macrophage colony-stimulating factor.

Henschler R, Lindemann A, Brach MA, Mackensen A, Mertelsmann RH, Herrmann F. Henschler R, et al. Among authors: lindemann a. FEBS Lett. 1991 May 20;283(1):47-51. doi: 10.1016/0014-5793(91)80550-m. FEBS Lett. 1991. Retraction in: FEBS Lett. 1998 Jun 16;429(3):426. PMID: 1709882 Free article. Retracted.

8

Serum cytokine levels in cancer patients treated with different schedules of ultra-low-dose interleukin-2.

Lindemann A, Brossart P, Höffken K, Flasshove M, Voliotis D, Diehl V, Kulmburg P, Wagner H, Mertelsmann R. Lindemann A, et al. J Immunother Emphasis Tumor Immunol. 1994 Apr;15(3):225-30. doi: 10.1097/00002371-199404000-00009. J Immunother Emphasis Tumor Immunol. 1994. PMID: 8032546 Clinical Trial.

9

Interleukin-3 and its receptor.

Lindemann A, Mertelsmann R. Lindemann A, et al. Cancer Treat Res. 1995;80:107-42. doi: 10.1007/978-1-4613-1241-3_5. Cancer Treat Res. 1995. PMID: 8821576 Review. No abstract available.

10

A phase-I clinical study of autologous tumor cells plus interleukin-2-gene-transfected allogeneic fibroblasts as a vaccine in patients with cancer.

Veelken H, Mackensen A, Lahn M, Köhler G, Becker D, Franke B, Brennscheidt U, Kulmburg P, Rosenthal FM, Keller H, Hasse J, Schultze-Seemann W, Farthmann EH, Mertelsmann R, Lindemann A. Veelken H, et al. Among authors: lindemann a. Int J Cancer. 1997 Jan 27;70(3):269-77. doi: 10.1002/(sici)1097-0215(19970127)70:3<269::aid-ijc4>3.0.co;2-v. Int J Cancer. 1997. PMID: 9033626 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

226 results

Search Page

Filters